2[1]Li Z Y,Tu X H.Current pharmacology research advances of safflor yellow[J].Traditional Chinese Drug Research ＆ Clinical Pharmacol ogy(中药新药与临床药),2005,16(2):153-156
3[2]Li F,Lou Y P,Wang X M.Protection of carthamfutinctorius on trans membrane potentials in papillary myocardium of guinea pig under Anoxia and Reoxygenation[J].Journal of HARBIN Medical Univer sity(哈尔滨医科大学学报),1999,33(1):6-9
4[4]Murry CE,Jennings RB,Reimer KA,et al.Preconditioning with ischemia:A delay of lethal cell injury in ischemic myocardium[J].Circulation,1986,74(5):1124-1136
5[5]Tsang A,Hausenloy DJ,Mocanu MM,et al.Postconditioning a form of "modifier reperfusion" protects the myocardium by activat ing the phosphatidylinositol-3-kinase-Akt pathway[J].Cite Res,2004,95:230-232
7Han SY,Kim HS. Spironolactone prevent diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats[J].Journal of the American Society of Nephrology,2006,(05):1362-1372.doi:10.1681/ASN.2005111196.
8Li J,Zhang S,Lu M. Hydroxysafflor yellow A suppresses inflammatory responses of BY2 microglia after oxygen-glucose deprivation[J].Neuroscience Letters,2013,(535):51-56.
9Sun L,Yang L,Xu YW. Neuroprotection ofhydroxysafflor yellow A in the transient focal ischemia:inhibition of protein oxidation/nitration,12/15-1ipoxygenase and blood-brain barrier disruption[J].Brain Research,2012,(1473):227-235.
